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Summary. In calcium homeostasis, vitamin D3 is a 
potent serum calcium-raising agent which in vivo 
regulates both calcitonin (CT) and parathyroid hormone 
(PTH) gene expression. Serum calcium is the major 
secretagogue for CT, a hormons  product whose 
biosynthesis is the main biological activity of thyroid C- 
cells. Taking advantage of this regulatory mechanism, 
long-term vitamin D3-induced hypercalcemia has been 
extensively used as a model to produce hyperactivation, 
hyperplasia and even proliferative lesions of C-cells, 
supposedly to reduce the sustained high calcium serum 
concentrations. We have recently demonstrated that CT 
serum levels did not rise after long-term 
hypervitaminosis D3. Moreover, C-cells did not have a 
proliferative response, rather a decrease in CT-producing 
C-cell number was observed. In order to confirm the 
inhibitory effect of vitamin D3 on C-cells, Wistar rats 
were administered vitamin D3 chronically (25,000 IUId) 
with or without calcium chloride (CaC12). Under these 
long-term vitaminD -hypercalcemic conditions, 
calcium, active metaboetes of vitamin 4 ,  CT and PTH 
serum concentrations were determined by RIA; CT and 
PTH mRNA levels were analysed by Northern blot and 
in situ hybridization; and, finally, the ultrastructure of 
calciotrophic hormone-producing cells was analysed by 
electron microscapy. Our results show, that, in rats, long 
term administration of vitamin D3 results in a decrease 
in hormone biosynthetic activities of both PTH and CT- 
producing cells, albeit at different magnitudes. Based 
upon these results, we conclude that hypervitaminosis 
D3-based methods do not stimulate C-cell activity and 
can not be used to induce proliferative lesions of 
calcitonin-producing cells. 
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lntroduction 
Calcitonin (CT), parathyroid hormone (PTH) and 
1,25-dihydroxycholecalciferol (1,25-(OH) D3), the 
active metabolite of vitamin D3, are the main t ormones 
involved in regulating calcium homeostasis. CT is 
produced mainly in the C cells, which represent about 
5% of al1 the endocrine cells in the rat thyroid gland 
(Martín-Lacave et al., 1992), while PTH is synthesized 
in the chief cells of the parathyroid gland. A high 
calcium stimulates CT secretion whereas a low calcium 
stimulates PTH secretion (Naveh-Many et al., 1992). 
Expression of the PTH gene is regulated by 1,25- 
(OH)2D3 and estrogens (Silver et al., 1985; Naveh-Many 
and Silver, 1990; Naveh-Many et al., 1992). PTH 
mRNA levels are reduced over 90% 24 hours after 1,25- 
(OH) D3 administration (Silver et al., 1985, 1986; 
~ a v e ? i - ~ a n ~  nd Silver, 1990). Moreover, 1,25- 
(OH)2D3 is a powerful inhibitor of CT gene 
transcription that reduces CT expression to 4% of basa1 
within 24 hours (Silver and Naveh-Many, 1993). in 
addition, estrogens, as in the case of PTH, induce CT 
gene expression. It has also been reported that chronic 
hypercalcemia induced by large doses of vitamin D3 
produces hypertrophic and hyperplastic changes of C- 
cells and has even been used as a model to induce 
proliferative lesions derived from them (Thurston and 
Williams, 1982; Capen and Martin, 1989; Okada et al., 
1991). However, in those studies, plasma calcitonin 
levels were not measured to verify the supposed 
increasing hormonal synthesis by C-cells. 
We have recently demonstrated that during a long- 
term hypercalcemia induced by vitamin D , calcitonin 
serum levels, and, also, the number o 9 calcitonin 
immunopositive cells of the thyroid gland, slightly 
decreased (Martín-Lacave et al., 1998). Those last 
results are in sharp contrast to previous papers reporting 
a hypertrophic and hyperplastic effect on C-celis after 
vitamin-D treatrnent (Zabel, 1976; Okada et al., 1991). 
Nevertheless, the effect of prolonged treatment with 
vitamin D3 metabolites on CT and PTH transcription 
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and secretion by specialized endocrine cells has not been 
examined yet. In this study, we present the different 
behaviour of C-cells and chief cells in the synthesis and 
release of calciotrophic hormones under a long-term 
treatment with pharmacological doses of oral vitamin 
D3. We demonstrate that vitamin D3-induced hyper- 
caleemia does not stimulate biosynthetic CT activity. 
Moreover, vitamin D3 long-term administration leads to 
a decrease in CT mRNA and CT serum levels and, also, 
in PTH mRNA and seric PTH; results which are not 
compatible with hyperactivation-mediated proliferative 
changes. 
Materials and methods 
Experimental model 
Male Wistar rats (n=90), aged 2 months, were 
divided into groups. Group O (n=10) was the no 
treatment control. Group 1 (n=20) was the control 
utilized at each timepoint. Group 11 consisted of 20 
anirnals receiving 50,000 IU of vitamin D (previously 
diluted in an alcoholic vehicle) per 100 nd of drinking 
water for either 1 or 2 months. On average, each subject 
drank over 50 m1 of this solution every day. Group 111 
consisted of 20 animals receiving the same treatment as 
group 11 plus 0.1% of CaC12. Finally, group IV: 20 
animals which received only 0.1% CaC12. In the course 
of the experiment, the rats were housed and handled 
according to approved guidelines, maintained under a 
standard laboratory diet and allowed water ad libitum. 
Animals were sacrificed under ether anaesthesia. Blood 
samples were taken by aortic puncture and thyro- 
parathyroid complexes were extracted and immediately 
either fixed or frozen in liquid nitrogen. 
Serum anaiysis 
Total serum calcium was determined using a calcium 
analyzer (Merck Vitalab Selectra). The leve1 of serum 
CT was determined using commercially available kits 
(Nichols Institute Diagnostics, CA, USA). The levels of 
serum PTH were determined using the Rat PTH (IRMA) 
Kit (Nichols Institute Diagnostics, CA, USA). Serum 
concentrations of 25-OHD3 were measured by RIA 
using a 25-hydroxyvitamin D, 125~ RiA Kit (INCSTAR 
Corporation-Stillwater, Minnesota, USA). The 
measurement of 1,25-(OH)2D3 levels was carried out 
using a RIA for the determination of 1,25- 
dihydroxyvitamin D (Nichols Institute Diagnostics CA, 
USA). Results were expressed as pg 1,25-(OH)2D3/ml 
rat serum. 
Probes 
For CT mRNA, a 45 base antisense oligodeoxy- 
nucleotide probe, complementary to 3' end of exon 4 
(Jacobs et al., 1981) was used. For PTH mRNA, a 
cocktail of two 45-base oligodeoxynucleotide antisense 
probes, corresponding to 3' and 5' end coding regions, 
respectively, was used (Heinrich et al., 1984). For 
GAPDH mRNA, a cocktail of two 45-base oligodeoxy- 
nucleotide antisense probes corresponding to NH2 and 
COOH ends of mature protein, respectively, was used. 
Sequences were chosen using the gcg Wisconsin 
Package and showed no homology with any other known 
sequence of Genebank Database. Antisense probes and 
complementary sense chains, used as negative controls, 
were 3'-OH end-tailed with Digoxigenin-11-dUTPIdATP, 
according to the manufacturer's instruction 
(Oligonucleotide Tailing Kit, Roche). 
Northern blof analysis 
Total thyro-parathyroid RNA was isolated as 
previously described (Chomczynski and Sacchi, 1987). 
Twenty p g  of total RNA was size fractionated by 
electrophoresis through 1% agarose/2% formaldehyde 
gel and transferred to nylon membrane (Bionylon Zt, 
Bioprobe). For hybridization, 30 nglml of specific probe 
was diluted in SxSSC, 0.1% N-Laurylsarcosyne, 0.02% 
SDS, 1% Blocking Reagent (Roche) and incubated 
overnight at 60  OC. After stringency washes, 
digoxigenin-labelled nucleotides were detected with 
alkaline phosphatase-linked anti-digoxigenin antibodies 
which were finally revealed by quimioluminescence. CT 
and PTH hybnd signals were normalized by subsequent 
hybridization of membranes with the GAPDH mRNA 
specific probe. Analysis of autoradiographs was 
performed using an image analysis program (NIH Image 
6.01). mRNA levels (the ratio of integrated intensities 
CTIGAPDH and PTHIGAPDH) were expressed in 
arbitrary units. CT and PTH mRNA levels in treated 
groups were expressed as % of control values. 
ln situ hybridization 
After the isolation, the thyro-parathyroid complex 
was fixed in 4% paraformaldehyde and paraffin- 
embedded. Paraffin-embedded 5 pm sections were 
deparaffinized, rehydrated and permeabilised with 
Proteinase K (Roche). For hybridization, 2 nglpl of 
specific antisense, or control sense oligonucleotide 
probe, was diluted in 50% deionized formamide, 10% 
dextran sulphate, 2xSSC, 0.lxTris-EDTA, 1 pglpl  
sonicated sperm salmon DNA, 5xDenhardt's solution. 
Sections were incubated overnight with 40 ,u1 of this 
solution, under coverslip, at 42 OC in humidity chamber. 
After extensive stringency washes, digoxigenin was 
detected using an anti-digoxigenin alkaline phosphatase- 
conjugated antibody which was subsequently detected 
by a standard histoenzymatic color reaction. Finally, 
sections were methyl green-counterstained and mounted 
with glycerol-gelatin. 
Electron micrmcopy 
Small fragments of thyroid-parathyroid complexes 
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Table 1. Body weight (g) and total s m m  calcium (mgldl) in control and experimental animals. 
TREATMENT BODY WElGHT (g) SERUM CALCIUM (mgldl) 
Months Months 
o 1 2 o 1 2 
Control 339133 480156 538171 
V i  D3 371 141 360I49* 353I46W 
Vit D3 + CaC12 347145 442142 401 143* 
CaCI, 369157 468160 398167 
MeanISD. *: Pe0.05; m : Pe0.01 *: PeO.001. Statisticai diierences versus control rats of same age. 
were fixed in 2.5% glutaradehyde and 2% para- 
formaldehyde in 0.1M phosphate buffer, pH 7.4, for 4 h, 
postfixed in Oso4  in the same buffer, dehydrated 
through graded alcohols, and embedded via propylene 
oxide in Spur. Ultrathin sections were counterstained 
with uranyl acetate and lead citrate. 
Statistical analysis 
Data were subjected to ANOVA. The mean values in 
each experiment were compared with the control group 
using Student's test. Results were given as mean ISEM. 
P values of less than 0.05 were accepted as significant. 
Results 
Effects on serum calcium and rat body weight 
The administration of vitamin D3 produced a 
marked increase in serum calcium concentration as 
compared with controls. Calcium concentration one 
month after treatment with vitamin D3 raised from 10.54 
mg/ml (normocalcemia) to 14.81 mg/ml (Table l), a 
state that can be characterized as severe sustained 
hypercalcemia. There was no significant change in 
calcium levels after two months of treatment. There was 
a significant decrease in the weight of the treated rats in 
comparison with the control rats. This decrease was 
more pronounced in rats without calcium chloride 
supplement in the drinking water. These rats also 
showed generalized weakness and increasing signs of 
cachexia following the treatment. In contrast, animals 
treated with calcium chloride done showed stable serum 
calcium levels and body weights. Therefore, further 
studies were limited to animals treated with vitamin D3. 
Effects on serum concentration of vitamin D3 metabolites 
The hypervitaminosis D3 state was mainly due to the 
Flg. 1. Serum levels of vitamin D3 metabolites in control rats and in rats 
treated either with vitamin D3 or vjtamin D3 plus calcium chloride. A. Serum 
25-OH-vitamin D3 and 1,25-(OH)2D3 levels in control rats. B. Serum 25 
OHD3 levels in control and experimental animals. C. Serum 1 ,25-(OH)2D3 
levels in control and experimental animals. Each bar represents the 
mean~SEM of 10 rats. *: P ~ 0 . 0 5 ; ~ :  Pc0.01; -: P<0.001 versus untreated 
rats. 
second main active metabolite of vitamin D3, the 25- 
OHD3: The administration of vitamin D3, combined or 
not with CaCl produced an approximately 10-fold 
increase of 25-8HD3 serum levels in al1 treated rats, as 
compared with control rats, whose basa1 25-OHD3 
serum levels did not vary at the daerent time-points of 
the experiment (Fig. 1B). In contrast with 25-OHD3 
data, the administration of vitamin D3 did not raise the 
serum levels of the most active metabolite of vitamin D3 
rime of tmatment (mnt&bS) ViL D, c 1- V ¡ D , + M ,  / 
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1,25-(OH)2D3 (Fig. 1C). As a result of the treatment, significant decrease in basa1 levels of 1,25-(OHhD3 was 
decreased serum l,25-(OH)2D3 values were found in al1 seen in 2-, 3- and 4-month-old control rats, which 
experimental animals. This effect was more evident after diminished more than 60% during this period of their 
the first month of  treatment. In relation to this, a lives (Fig. 1A). 
Table 2. Changes of serum calcitonin and PTH levels under long-ten hypewitaminosis DB 
TREATMENT SERUM CALClTONlN (pgtml) 
months 
1 2 
SERUM PTH @g/ml) 
months 
1 2 '  
Control 21.9412.95 49.3011 0.05 
V I  D3 25.16I9.19 26.7916.- 
V I  D3 + C&I2 29.6017.49 30.2813.67- 
MeaniSD. *: P<0.05; *: P<0.001. Statistical dierences versus control rats of same age. 
A Time of treahent 
1 month 2 months 
GAPDH mRNA+ 
1.27 kb 
Time of treatment 
1 month 2 months 
1 
Time of treatment (months) 
Time of trattment (montbs) 
Flg. 2. Detecüon of CT and PTH mRNAs by Northem blot analysis aíter 1 and 2 months of treatment with vitamin D3 and vitamin D, with calcium 
chloride. A. Gel blot of total RNA from thyroid-parathyroid tissue hybridized sequentially for CT mRNA and GAPDH mRNA. Twenty pg were applied on 
each line. Lanes: 1, control group; 2, vitamin D3-treated group; 3, vitamin D3+CaC12-treated group. Figure represents the results of one representative 
out of h e  equivalent expeitments. Relative CT mRNA levels of control and experimental rats. Results are shown as the meaniSEM for 5 different 
8XperlmentS. B. Gel blot of total RNA from thyroid-parathyroid tissue hybridized sequentially for PTH mRNA and GAPDH mRNA. Twenty pg were 
applied on each line. Lanes: 1, control group; 2, vitamin D3-treated group; 3. vitamin D,+CaC12-treated group. Figure represents the results of one 
representaüve out of five equhralent experiments. Relative CT mRNA levels of control and experimental rats. Results are shown as the mean~SEM for 
5 diiferent experiments. 
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Effects on CT expression and CT serum concentration month of vitamin D3 treatment (Fig. 2). This decrease 
was fairly small in the group treated with vitamin Dg and 
A moderate decrease in the steady-state CT mRNA calcium chloride. CT gene expression decreased more 
levels was found by Northern blot analysis after one significantly in both groups after two months of  
Fig. 3. Detection of CT ) and PTH mRNAs (DF) by in siiu hybridization on rat i 1-parathyroid gland r 2 rnonth treatrnent. A. Control rt 
There is a clear localization of CT mRNA in al1 C cells. B. Vltamin D3-treated rats: There is a reduction in the amount of CT rnRNA which makes the 
identiñcation of the C cells d icul t  in comparison with control glands. C. Vitamin D3+CaC12-treated rats: the staining of C cells with the CT probe is 
more reduced than in control glands but slightly higher in comparison with vitamin D3-treated rats. x 400. Bar: 25 prn. D. Control rat: There is a clear ' 
localization of WH mRNA in al1 chief cells. E. Vitamin D3-treated rats: There is a complete reduction in the amount of PTH mRNA which makes the 
parathyroid gland negatively stained. F. Vitamin D3+CaC12-treated rats. P: parathyroid gland; T: thyroid gland. x 200. Bar :50 pm. 
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treatment. Thyroid sections stained by in s i tu  
hybridization corroborate the decrease in the amount of 
CT mRNA in C cells after vitamin-D treatrnent, however 
the proportion of CT mRNA positive cells seemed not to 
vary in comparison to controls (Fig. 3). Similarly, the 
decrease in serum CT concentration was more 
pronounced in the group treated with vitamin D3, and, 
also, more evident after the second month of treatment 
(Table 2). 
Effects on PTH expression and PTH serum 
wncentration 
The administration of vitamin D3 strongly inhibited 
the expression of the PTH gene. As can be seen in Figs. 
2,3, the amount of PTH mRNA became undetectable by 
Northern blot analysis of 10 p g  of total thyroparathyroid 
RNA and by in situ hybridization. No differences were 
obsewed with the addition of calcium chloride. As a 
result, PTH levels in serum were markedly decreased 
(Table 2), becaming undetectable after one month of 
treatment. 
Effects on the ultrastructure of C cells and chief cells 
In comparison with control rats, secretory granules 
of C-cells in al1 treated animals were markedly reduced 
in number but they did not disappear completely. The 
Golgi apparatus was moderately developed and the 
endoplasmic reticulum was mostly vesicular in shape 
Flg. 4. Ultrastnictural irnages of Ccells (A, B) and chief cells (C, D) belonging to control rats (A, C) and vitamin D3-treated rats (6, D). As can be 
observed, in the thyroid gland (A, B) there is a marked decrease in the nurnber of secretory granules contained in the cytoplasm of the C cells v) under 
hypervitaminosis D,. In the parathyroid gland (C, D), under hype~itamin0Sis D, conditions, there is a reduction in the complexity of membrane 
infoldings (arrows) in the chief cells, and an increase in the number of empty vesicles (anow heads). x 4,400. Bar: 2,3 prn. 
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and somewhat decreased in volume. Therefore, the 
cytoplasm of the degranulated cells was much clearer 
than that of the normaliy granulated cells (Fig. 4A,B). In 
the parathyroid glands of treated rats, the majority of 
chief cells were characterized by the presence of 
numerous empty vesicles of different sizes in the 
cytoplasm (Fig. 4C,D). Furthermore, the experimental 
rats presented chief cells with less complex infoldings of 
the cellular membrane than in control animals. Different 
organelles such as rough endoplasmic reticulum and free 
ribosomes, appeared to be similar to those of non-treated 
rats. 
Discussion 
The results of our investigations, together with some 
literature data, support our first hypothesis that C-cells, 
in a hypercalcemic state due to an intoxication with 
vitamin D3, do not respond with hypertrophic and 
hyperplastic changes, but rather in these conditions, the 
main biosynthetic activity of C-cells is inhibited 
(Martín-Lacave et al., 1998). The hypervitaminosis D3 
state obtained in our experimental model was mainly due 
to the rising of 25-OHD3 serum levels. 25-OHD3 is the 
first active and most abundant metabolite in the pathway 
of vitamin D3 activation (Parfitt, 1999). Conversion of 
vitamin D3 in 25-OHD is not subjected to strict ? regulation and basical y depends on vitamin D3 
availability (Reichel et al., 1989). In our experiment, 
non-treated experimental rats, aged 2, 3 and 4 months, 
showed similar serum 25-OHD3 values, whereas the oral 
administration of vitamin D3 led to a ten-fold increased 
in serum levels of 25-OHD . In contrast, synthesis and 
degradation of 1,25-(OH) d3 (the most active vitamin T D3 metabolite) are strict y down regulated by serum 
calcium, and up regulated by calcitonin and PTH 
(Kawashirna et al., 1981; Shigematsu et al., 1986; Sinki 
et al., 1992). Based on this, as a result of the 
hypercalcemia and decreased levels of serum calcitonin 
and PTH, lower levels of 1,25-(OH)2D3 were observed 
in both treatment groups. In our study we have also 
obsewed a decrease in 1,25-(0 D3 serum levels with 
age in control animals. A similar 9 ecrease has also been 
described in humans with aging (Fujisawa et al., 1984; 
Quesada et al., 1994). This observation, in our 
experimental model, might be related to developmental 
calcium requirements rather than changes caused by the 
prolongation of the treatment. 
In chronic hypervitaminosis D , such as in the 
experimental model we have presented, parathyroid cells 
must respond to both Ca++ and vitamin D3: which act 
synergistically on PTH expression and secretion. Steady- 
state levels of PTH mRNA dramaticaly decreased (as 
assessed by either Northern blotting or in situ 
hybridization). This, in turn, results in undetectable 
levels of serum PTH. These patterns of PTH expression 
and secretion are similar to those elicited by short-term 
treatments with 1,25-(OH)2D3 (Karmali et al., 1989; 
Naveh-Many et al., 1989, 1992; Naveh-Many and Silver 
1990; Moallem et al., 1998). Ultrastructural appearance 
of the parathyroid gland in long-term vitamin-treated 
rats also coincides with that seen in chief cells under 
short-term hypercalcemia or hypervitaminosis D 
(Setoguti et al., 1981, 1995; Wild et al., 1985). The 
apparent degradation of storage grandes by hydrolysis, 
and the decrease of the cell surface area, seems to be 
closely associated with an intracellular regulatory 
mechanism for PTH secretion. 
HypeMtaminosis D3 afEects CT-producing celís in a 
distinctly different manner. C-cell population may 
respond to the increase in extracellular calcium by 
releasing CT stored in granules through exocytosis. 
However, vitamin Dgm reduces the transcription of the CT 
gene. CT secretion @ves the cells an almost completely 
degranulated appearance under electron microscopy. 
Nonetheless, they stiIl conserve morphological signs of 
the persistence of some hormonal synthesis. These 
ultrastructural findings concur with those obtaiited by in 
situ hybridization and Northern blot analysis. Based 
upon these, C-cells, still have a moderate rate of CT 
synthesis which is  not observable in short-term 
treatments, where CT mRNA decreased 4% of baseline 
level at 48 h Waveh-Many and Silver, 1988; Silver and 
Naveh-Many, 1993). Importantly, in these studies, 1,25- 
(OH)2D3 did not raise serum calcium. These results 
indicate that in the case of C-celis, where hyperdcemia 
and hypervitaminosis DJ are antagonic stimuli, a second 
hormone synthesis regulatory mechanism, besides the 
vitamin D3-mediated transcriptional inhibition or mRNA 
stability, would be present. 
In the group treated with vitamin D? and CaCi2, CT 
mRNA levels were higher than those elicited by vitamin 
D3 alone. In this case, the effect of calcium ingestion on 
the release of different mediators at the gastrointestinal 
level, such as gastrin, cholecystokinin and glucagon, 
might be a decisive factor. These hormones are well- 
known CT secretagogues and are also involved in 
regulating calcitonin gene tranwiption (Naueh-Many 
and Silver, 1988; Raue et al., 1991, 1993). The 
administration of CaC12 with vitamin D3 in the drinking 
water may thus act as a "buf€erl' against the 25-OHD3 - 
induced blockade of CT synthesis. 
In numerous studies in which vitamin D3 has been 
used as a serurn-calcium-raising agent, to investigate the 
reaction of C cells to long-term hypercalcemia, C-cell 
hypertrophy and hyperplasia has been described (Zabel, 
1976; Thurston and Williams, 1982; Kameda et al., 
1985; Capen and Martin, 1989; Okada et al., 1991). We 
have recently described (Martln-Lacave et al., 1998) the 
effect of long-term administration of vitamin D3 at 
hyperdcemic doses on the thyroid gland of the rat. In 
contrast bo previous reports, we have found that C cells 
did not respond with hypertrophic and hyperplastic 
changes. In addition, the number of C cells that were 
immunopositive for CT decreased. This observation 
concurs with the findings of our current study in which 
vitamin D does not stimulate the C-cell population, but 
rather inhhits CT synthesis. Based upon these resulb it 
is difficult to accep-t that hypewitaminosis D , which 
inhibits the main biosynthetic activity of c-ceds, could 
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induce proliferative changes in this endocrine 
population. We conclude that the oral administration of 
vitamin D3 at serum-calcium-raising doses for prolonged 
periods reduces the rate of biosynthesis and secretion of 
both PTH and CT. Therefore, supporting our previous 
data (Martín-Lacave et al., 1998), hypervitaminosis D3- 
based methods are not reliable models to induce 
proliferative lesions of calcitonin-producing cells, as has 
been extensively described in the literature. 
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